Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyaluronic acid + corticosteroid is a combination therapy used primarily for the intra-articular treatment of osteoarthritis, especially of the knee. Hyaluronic acid acts as a viscosupplement, improving joint lubrication and potentially providing longer-term pain relief and improved function in osteoarthritic joints. Corticosteroids provide rapid, short-term reduction in inflammation and pain by acting on nuclear steroid receptors to suppress inflammatory pathways, reduce vascular permeability, inhibit accumulation of inflammatory cells, and decrease production of pro-inflammatory mediators such as prostaglandins and leukotrienes. This combination may be used when monotherapy with either agent is insufficient for symptom control[1][2][4]. The primary indication is symptomatic management of moderate to severe osteoarthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hyaluronic acid + corticosteroid.